Pharmaceutical

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Rusan Pharma's new facility in India will enhance its global capabilities and expand its API product portfolio.

Jul 22, 2024 - 04:00
Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval
Rusan Pharma's new facility in India will enhance its global capabilities and expand its API product portfolio.
Read the original article

Tags:

Previous Article

New genetic test will eliminate a form of inherited blindness in dogs

Next Article

Certara sees highest patent filings and grants during June in Q2 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Idorsia’s Quviviq receives marketing authorisation from Health Canada

Idorsia’s Quviviq receives marketing authorisation from...

May 4, 2023

US FDA grants approval for Pfizer’s lung cancer combination treatment

US FDA grants approval for Pfizer’s lung cancer combina...

Oct 13, 2023

EC grants approval for Menarini’s breast cancer therapy

EC grants approval for Menarini’s breast cancer therapy

Sep 21, 2023